The IVF (In Vitro Fertilization) market encompasses a range of technologies integrated into devices designed to enhance the efficiency, accuracy, and success rates of fertility treatments. These technologies play critical roles in various stages of IVF, from egg retrieval and embryo culture to embryo transfer.
Although IFV has helped many people achieve their dream of parenthood, it remains an emotionally challenging process, in part due to its low success rate: only one in three procedures were successful for women under 35 years old who underwent IVF in the UK, with the percentage lowering to 5% for women aged 43 and over, according to NHS figures.
Growth in the In Vitro Fertilisation market is also limited by its high costs. Today, innovators are turning to new medical devices and technology to optimise each step of the process in terms of both efficacy and efficiency.
Perdigó brings a wealth of experience in the development of IVF medical devices, including specialised tools for immature oocyte retrieval, AI-driven automated intracytoplasmic sperm injection (ICSI), and advanced embryo transfer systems.
The company’s technological expertise and multidisciplinary engineering, including microfluidics, medical device electronics, and usability, are dedicated to supporting pioneers seeking a step change in success rates and cost-effectiveness
"Perdigó showed great commitment to deliver groundbreaking technology in the field of IVF, demonstrating deep engineering and medical device expertise."
Ana García Poyo, VP Op. and Chief Industrial Officer
“Perdigó has performed thorough Design Verification Testing on our devices. Thanks to their work, we are confident in the success of the upcoming regulatory submission of our medical device.”
Maria Climent QA & RA manager Premium Fertility
